Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.40 |
| ▸ | HMGCR | P04035 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 4/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27536442 | 0.83 | CYP3A4 (0.56) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL888619 | 0.81 | HMGCR (0.47) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL18077339 | 0.81 | HMGCR (0.39) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL11706875 | 0.80 | GAA (0.42) | CYP3A4ALDH1A1TSHRLMNAGAA | |
| SCHEMBL283905 | 0.80 | CYP3A4 (0.51) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL9659019 | 0.79 | CYP3A4 (0.47) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL6228436 | 0.79 | CYP3A4 (0.47) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL2679983 | 0.78 | ALDH1A1 (0.46) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL9845247 | 0.78 | ALDH1A1 (0.44) | CYP3A4HMGCRALDH1A1TSHRLMNA | |
| SCHEMBL9674260 | 0.78 | ALDH1A1 (0.44) | CYP3A4HMGCRALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101528668-B | Macromolecular amine-phenolic antioxidant compositions, its production technology and use | SI GROUP INC. (US) | 2016-04-20 | — | — | CN | disclosed |
| EP-2662351-B1 | Alkylated heterocyclic reaction products useful as antioxidants | SI GROUP INC (US) | 2016-03-30 | — | — | EP | disclosed |
| EP-2084142-B1 | ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS | SI GROUP INC (US) | 2016-03-23 | — | — | EP | disclosed |
| EP-2079677-B1 | MACROMOLECULAR AMINE-PHENOLIC ANTIOXIDANT COMPOSITIONS, PROCESS TECHNOLOGY THEREOF, AND USES THEREOF | ALBEMARLE CORP (US) | 2014-07-09 | — | — | EP | disclosed |
| CN-101610992-B | Alkylated heterocyclic reaction products useful as antioxidants | ALBEMARLE CORP | 2014-04-16 | — | — | CN | disclosed |
| EP-2662351-A1 | Alkylated heterocyclic reaction products useful as antioxidants | Albemarle Corporation (US) | 2013-11-13 | — | — | EP | disclosed |
| US-8455414-B2 | Macromolecular amine-phenolic antioxidant compositions, process technology thereof, and uses thereof | ALBEMARLE CORPORATION (US) | 2013-06-04 | — | — | US | disclosed |
| US-8410084-B2 | Alkylated heterocyclic reaction products useful as antioxidants | ALBEMARLE CORPORATION (US) | 2013-04-02 | — | — | US | disclosed |
| US-20120115764-A1 | MACROMOLECULAR AMINE-PHENOLIC ANTIOXIDANT COMPOSITIONS, PROCESS TECHNOLOGY THEREOF, AND USES THEREOF | ALBEMARLE CORPORATION (US) | 2012-05-10 | — | — | US | disclosed |
| US-20100041730-A1 | ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS | ADDIVANT USA, LLC | 2010-02-18 | — | — | US | disclosed |
| EP-2084142-A2 | ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS | Albermarle Corporation (US) | 2009-08-05 | — | — | EP | disclosed |
| EP-2079677-A2 | MACROMOLECULAR AMINE-PHENOLIC ANTIOXIDANT COMPOSITIONS, PROCESS TECHNOLOGY THEREOF, AND USES THEREOF | Albermarle Corporation (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2009073378-A1 | INDUSTRIAL OIL FORMULATIONS CONTAINING MACROMOLECULAR ANTIOXIDANTS | ALBEMARLE CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| WO-2008048988-A2 | ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS | ALBEMARLE CORPORATION (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008048989-A2 | MACROMOLECULAR AMINE-PHENOLIC ANTIOXIDANT COMPOSITIONS, PROCESS TECHNOLOGY THEREOF, AND USES THEREOF | ALBEMARLE CORPORATION (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008048990-A2 | PROCESSES SUITABLE FOR PRODUCING MACROMOLECULAR ANTIOXIDANT COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2008-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115764-A1 | MACROMOLECULAR AMINE-PHENOLIC ANTIOXIDANT COMPOSITIONS, PROCESS TECHNOLOGY THEREOF, AND USES THEREOF | PNMT, COMT, MAOA | CYP3A4 600/4885HMGCR 1872/4885ALDH1A1 957/4885 |
| US-20100041730-A1 | ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS | GPX4, AOX1, SQOR | CYP3A4 169/4885HMGCR 917/4885ALDH1A1 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.